期刊文献+

右丙亚胺对表柔比星心脏毒性防治的临床观察 被引量:5

下载PDF
导出
摘要 目的观察右丙亚胺对表柔比星所致心脏毒性的保护作用。方法选取60例化疗方案中含有表柔比星的乳腺癌、淋巴瘤患者,按病种化疗4周期后,随机分为对照组28例、治疗组32例,治疗组DEX联合原化疗方案化疗2周期,对照组继续按原方案化疗2周期,观察BNP、c In1及心电图变化。结果治疗后各观察时间点BNP、c In1、心电图变化均有差异(P<0.05)。结论右丙亚胺对表柔比星导致的心脏毒性有明显的防治作用。
出处 《泰山医学院学报》 CAS 2015年第11期1292-1293,共2页 Journal of Taishan Medical College
  • 相关文献

参考文献5

  • 1Ramirez-Ramirez MA, Sobrino-Cossio S, de la Mora-Levy JG, et al. Loss of expression of DNA mismatch repair proteins in aberrant crypt foci indetifued in vivo by magnifying colonoscopy in subjects with hereditary nonpilyposic and sporadic colon rectal cancer[ J]. J Gastrointcst Cancer,2012,12(2) :209 -214.
  • 2李丹,张颖超,张志军,焦晓燕,徐晓华.右丙亚胺对女性乳腺癌患者术后化疗的心脏保护作用[J].中国肿瘤,2009,18(5):424-427. 被引量:3
  • 3Yeh ET,Tong AT, Lenihan DJ, et al. Catdiovascular complications of cancer therapy: diagnosis, pathogenesis, and managment [ J ]. Circulation,2004,109:3122 - 3131.
  • 4李峻,肖祥胜.右丙亚胺对接受含蒽环类药物女性乳腺癌患者的心脏保护作用前瞻性研究[J].湖南中医药大学学报,2012,32(2):48-50. 被引量:22
  • 5Albini A, Pennesi G, Donatelli F, et al. Cardiotoxicity of anticancer drugs: the need for eardio-oneology and cardiooneological preven- tion I J ]. J Natl Cancer Inst, 2010,102 ( 1 ) : 14 - 25.

二级参考文献14

  • 1于亚平.抗肿瘤药物的心脏毒性[J].现代肿瘤医学,2006,14(12):1628-1630. 被引量:11
  • 2董建红,张燕,苏喜改,吴琳.参麦注射液联合香丹注射液预防蒽环类化疗药物所致心脏毒性的临床观察[J].现代中西医结合杂志,2007,16(2):177-178. 被引量:13
  • 3张小花,姜志荣,李大海,褚强.蒽环类药物对肿瘤患者左心功能影响的组织多普勒评价[J].临床超声医学杂志,2007,9(3):151-153. 被引量:11
  • 4Swain SM,Whaley FS,Ewer MS,et al. Congestive heart fail- ure in patients treated with doxorubicin: a retrospective analysis of three trials[J]. Cancer, 2003,97 (2) :2869-2879.
  • 5Swain SM,Vici P. The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review[J]. J Cancer Res Clin Oncol, 2004, 130 (25): 1-7.
  • 6Marty M,Espie M, Llombart A, et al. Multieenter randomized phase Ⅲ study of the cardioprotective effect of dexrazoxane (Cardioxane) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy[J]. Ann Oncol, 2006, 17(9): 614-622.
  • 7Salvatorelli E, Menna P, CascegnaS, et al. Paclitaxel and docetaxel stimulation of doxorubicinol Formation in the human heart: implications for cardiotoxicity of doxoru- bicin-taxane chemotherapies[J]. JPET, 2006, 318(5):424- 433.
  • 8SESSA C, PAGANI O. Docetaxel and epirubicin in advanced breast cancer[J].Oncologist 2001,6(suppl 3): 13 - 16.
  • 9Lipshuhz SE, Rifai N, Dalton VM, et al. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia [J]. N Engl J Med, 2004, 351 (43): 145-153.
  • 10Marty M, Espie M,Llombart A,et al.Multieanter randomized phase III study of the eardioproteetive effect of dexrazoxane (Cardioxane) in advanced/metastatic breast cancer patients treated with anthraeyeline- based ehemotherapy[J].Annals of Oneology,2006,17(2):614-622.

共引文献23

同被引文献38

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部